MO

A Short Intro for Altria Investors

We've been asking ourselves recently if the market has placed a fair valuation on Altria. Let's dive into some of the fundamental values of this large-cap Consumer Defensive company to determine if there might be an opportunity here for value-minded investors.

Altria Is Overpriced:

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company belongs to the Consumer Defensive sector, which has an average price to earnings (P/E) ratio of 24.36. In contrast, Altria has a trailing 12 month P/E ratio of 11.2 based on its earnings per share of $3.8.

There is an important limit on the usefulness of P/E ratios. Since the P/E ratio is the share price divided by earnings per share, the ratio is determined partially by market sentiment on the stock. Sometimes a negative sentiment translates to a lower market price and therefore a lower P/E ratio -- and there might be good reasons for this negative sentiment.

One of the main reasons not to blindly invest in a company with a low P/E ratio is that it might have low growth expectations. Low growth correlates with low stock performance, so it's useful to factor growth into the valuation process. One of the easiest ways to do this is to divide the company's P/E ratio by its expected growth rate, which results in the price to earnings growth, or PEG ratio.

Altria's PEG ratio is 2.4, which shows that the stock is overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

The Company May Be Profitable, but Its Balance Sheet Is Highly Leveraged:

2018-05-31 2019-05-29 2020-05-19 2021-02-26 2022-02-25 2023-02-27
Revenue (MM) $25,576 $25,364 $25,110 $26,153 $26,013 $25,096
Gross Margins 47.0% 48.0% 72.0% 70.0% 73.0% 74.0%
Operating Margins 38% 37% 42% 42% 44% 47%
Net Margins 40.0% 27.0% -5.0% 17.0% 10.0% 23.0%
Net Income (MM) $10,222 $6,963 -$1,293 $4,467 $2,475 $5,764
Net Interest Expense (MM) -$705 -$665 -$1,280 -$1,209 -$1,162 -$1,058
Depreciation & Amort. (MM) -$209 -$227 -$226 -$257 -$244 -$226
Earnings Per Share $5.32 $3.69 -$0.69 $2.4 $1.35 $3.22
EPS Growth n/a -30.64% -118.7% 447.83% -43.75% 138.52%
Diluted Shares (MM) 1,921 1,888 1,869 1,859 1,832 1,790
Free Cash Flow (MM) $5,100 $8,629 $8,083 $8,616 $8,574 $7,461
Capital Expenditures (MM) -$199 -$238 -$246 -$231 -$169 $795
Net Current Assets (MM) -$23,440 -$36,511 -$38,090 -$37,332 -$35,046 -$33,657
Long Term Debt (MM) $13,030 $11,898 $27,042 $27,971 $26,939 $25,124
Net Debt / EBITDA 1.29 2.51 2.42 2.2 1.99 1.86

Altria has slimmer gross margins than its peers, declining EPS growth, and a highly leveraged balance sheet. On the other hand, the company has average operating margins with a stable trend working in its favor. Furthermore, Altria has weak revenue growth and a flat capital expenditure trend and irregular cash flows.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS